Skip to main content

Pfizer could know if COVID-19 vaccine candidate is effective by end of October

Shares of Pfizer Inc. rallied in premarket trading Friday, after the drugmaker said it is on track to know whether its potential COVID-19 vaccine is effective by the end of October, and currently expects to apply for Emergency Use Authorization by the second-half of November.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.